Genetic basis of anthracyclines cardiotoxicity: Literature review
The purpose of this review was to systematize data on molecular genetic markers of increased risk of cardiotoxic effects, as well as to search for risk and protective variants of candidate genes. Today, the therapy of malignant neoplasms is based on the use of anthracyclines – drugs of the cytostati...
Enregistré dans:
Auteurs principaux: | M. Yu. Sinitsky, A. V. Tsepokina, M. V. Khutornaya, A. V. Ponasenko, A. N. Sumin |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3824f05d5c5d4a4193d6bca3f450f543 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
par: Caterina Beatrice Monti, et autres
Publié: (2021) -
Impacto cardiovascular secundario a la terapia para el control del cáncer
par: Ríos,Juvenal A., et autres
Publié: (2020) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
par: Sousa,MG, et autres
Publié: (2014) -
Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network
par: Guoxing Wan, et autres
Publié: (2021) -
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
par: Alejandro Velasco-Ruiz, et autres
Publié: (2021)